The global antidiarrheal drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The antidiarrheal drug is used to relieve the symptoms of diarrhea. Diarrhea is a non-serious condition that can be treated with over-the-counter medicines. The major factor for the growth of the global antidiarrheal market during the forecast period is the high prevalence of diarrhea cases. According to World Health Organization (WHO), diarrhea is the second leading cause of mortalities in children under five years old and was responsible for the mortalities of 370,000 children in 2019. Additionally, there are 1.7 billion cases of childhood diarrhea every year globally. Hence, the growing prevalence of diarrhea among children is driving the growth of the global antidiarrheal drugs market during the forecast period.

Some key players in the market include Lupin Ltd., GlaxoSmithKline plc, and Pfizer, Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in March 2021, Lupin launched the generic version of Alinia (nitazoxanide) tablets, 500 mg of Romark Laboratories. These tablets are used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients of age 12 years and older.

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment covered- 

o By Type

o By Application

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape-Lupin Ltd., GlaxoSmithKline plc, and Pfizer, Inc., among others.

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How players are addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Antidiarrheal Drugs Market Report by Segment

By Type 

• OTC Drugs

• Prescription Drugs

By Application

• Children

• Adults

• Older People

Global Antidiarrheal Drugs Market Report by Region

North America

• United States

• Canada

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa